Trial Profile
Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Etoricoxib (Primary)
- Indications Headache
- Focus Therapeutic Use
- 21 Dec 2009 Results were published in Headache.
- 21 Dec 2009 Primary endpoint 'Headache frequency' has been met.
- 01 Oct 2008 New trial record.